{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:24:04Z","timestamp":1784996644862,"version":"3.55.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ejmech.2012.10.035","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T18:17:37Z","timestamp":1351793857000},"page":"75-90","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors"],"prefix":"10.1016","volume":"59","author":[{"given":"Aliuska Morales","family":"Helguera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"P\u00e9rez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cagide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Vina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Nat\u00e1lia D.S.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2012.10.035_bib1","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1517\/14656566.9.16.2759","article-title":"The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy","volume":"9","author":"Elmer","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2012.10.035_bib2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","article-title":"Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease","volume":"29","author":"Chen","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejmech.2012.10.035_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2012.10.035_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4140\/TCP.n.2011.48","article-title":"Selegiline and rasagiline: twins or distant cousins? guidelines","volume":"26","author":"Knudsen Gerber","year":"2011","journal-title":"Consult Pharm."},{"key":"10.1016\/j.ejmech.2012.10.035_bib5","doi-asserted-by":"crossref","first-page":"161S","DOI":"10.1592\/phco.27.12part2.161S","article-title":"Pharmacotherapy for Parkinson's disease","volume":"27","author":"Chen","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2012.10.035_bib6","doi-asserted-by":"crossref","first-page":"e1616","DOI":"10.1371\/journal.pone.0001616","article-title":"MAO B elevation in mouse brain astrocytes results in Parkinson's pathology","volume":"3","author":"Mallajosyula","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2012.10.035_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1046-2023(02)00083-X","article-title":"Monoamine oxidase: radiotracer development and human studies","volume":"27","author":"Fowler","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.ejmech.2012.10.035_bib8","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.4088\/JCP.11096tx6c","article-title":"MAOIs and transdermal delivery","volume":"73","author":"Vandenberg","year":"2012","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.ejmech.2012.10.035_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S1092852900014498","article-title":"Transdermal selegiline: the new generation of monoamine oxidase inhibitors","volume":"11","author":"Patkar","year":"2006","journal-title":"CNS Spectrum."},{"key":"10.1016\/j.ejmech.2012.10.035_bib10","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2741\/3069","article-title":"The neuroprotective mechanism of action of the multimodal drug ladostigil","volume":"13","author":"Weinreb","year":"2008","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"10.1016\/j.ejmech.2012.10.035_bib11","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1016\/j.bmcl.2004.08.066","article-title":"QSAR modeling of the MAO inhibitory activity of xanthones derivatives","volume":"14","author":"N\u00fa\u00f1ez","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.ejmech.2012.10.035_bib12","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1021\/jm9010127","volume":"52","author":"Pisani","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib13","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.bmcl.2009.07.039","article-title":"Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors","volume":"19","author":"Matos","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.10.035_bib14","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1016\/j.bmcl.2009.04.085","article-title":"A\u00a0new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors","volume":"19","author":"Matos","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.ejmech.2012.10.035_bib15","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1016\/j.bmc.2009.07.033","article-title":"Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors","volume":"17","author":"G\u00f6khan-Kelek\u00e7i","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib16","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1016\/j.ejmech.2010.07.005","article-title":"Inhibition of monoamine oxidase by indole and benzofuran derivatives","volume":"45","author":"Prins","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib17","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1016\/j.bmcl.2010.09.061","article-title":"Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors","volume":"20","author":"Fioravanti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.10.035_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0223-5234(97)88914-3","article-title":"Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocyclic compounds","volume":"32","author":"Wouters","year":"1997","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib19","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1021\/jm00019a018","article-title":"Inhibition of monoamine oxidase-b by 5H-Indeno[1,2c]pyridazines: biological activities, quantitative structure-activity relationships (QSARs) and 3D-QSARS","author":"Kneub\u00fchler","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib20","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.bmcl.2010.03.081","article-title":"Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B","volume":"20","author":"Alcaro","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.10.035_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bmcl.2010.11.128","article-title":"Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors","volume":"21","author":"Gaspar","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.10.035_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/cmdc.201000452","article-title":"Towards the discovery of a novel class of monoamine oxidase inhibitors: structure\u2013property\u2013activity and docking studies on chromone amides","volume":"6","author":"Gaspar","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2012.10.035_bib23","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/jm2004267","article-title":"Chromone a privileged scaffold for the development of monoamine oxidase inhibitors","volume":"54","author":"Gaspar","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2174\/092986706776872907","article-title":"Synthesis, biological evaluation and 3D-QSAR of 1,3,5-Trisubstituted-4,5-Dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase a inhibitors","volume":"13","author":"Chimenti","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2174\/156802608786786598","article-title":"Applications of 2D descriptors in drug design: a DRAGON tale","volume":"8","author":"Helguera","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/ci9802068","article-title":"Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis","volume":"38","author":"Medvedev","year":"1998","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2012.10.035_bib27","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1021\/jm001028o","article-title":"Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs","volume":"43","author":"Gnerre","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib28","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1021\/jm800656v","article-title":"Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors","volume":"51","author":"Santana","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/jm00250a008","article-title":"Discriminant analysis of the relationship between physical properties and the inhibition of monoamine oxidase by aminotetralins and aminoindans","volume":"17","author":"Martin","year":"1974","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib30","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1021\/jm0493109","article-title":"Sulfur-substituted r-alkyl phenethylamines as selective and reversible MAO-a inhibitors: biological activities, CoMFA analysis, and active site modeling","volume":"48","author":"Gallardo-Godoy","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbrc.2007.06.055","article-title":"Molecular docking of inhibitors into monoamine oxidase B","volume":"360","author":"Harkcom","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2012.10.035_bib32","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1016\/j.bmc.2010.05.070","article-title":"Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors","volume":"18","author":"Chimenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1573408052952711","article-title":"Monoamine oxidase inhibition in the light of new structural data","volume":"1","author":"Reyes-Parada","year":"2005","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.ejmech.2012.10.035_bib34","series-title":"Chemoinformatics: Concepts, Methods, and Tools for Drug Discovery","article-title":"Methods in molecular biology","author":"Bajorath","year":"2004"},{"key":"10.1016\/j.ejmech.2012.10.035_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1008194019144","article-title":"Computational methods for the structural alignment of molecules","volume":"14","author":"Lemmen","year":"2000","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2012.10.035_bib36","doi-asserted-by":"crossref","first-page":"9750","DOI":"10.1073\/pnas.1633804100","article-title":"Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures","volume":"100","author":"Binda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2012.10.035_bib37","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-A\u00b0 resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2012.10.035_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/qsar.200390007","article-title":"The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models","volume":"22","author":"Tropsha","year":"2003","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.ejmech.2012.10.035_bib39","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1021\/jm991164x","article-title":"Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR\/CoMFA analysis, and computational simulation of ligand recognition","volume":"43","author":"Moron","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/prep.2001.1546","article-title":"Highlevel expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae","volume":"24","author":"Li","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2012.10.035_bib41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/prep.2000.1309","article-title":"High-level expression of human liver monoamine oxidase B in Pichia pastoris","volume":"20","author":"Newton-Vinson","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2012.10.035_bib42","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/jm031087c","article-title":"Crystal structures of MAO B in complex with four inhibitors of the N-propargylaminoindan class","volume":"47","author":"Binda","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib43","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/jm801590u","article-title":"Chalcones: a valid scaffold for monoamine oxidases inhibitors","volume":"52","author":"Chimenti","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib44","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/jm801496u","article-title":"Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins","volume":"52","author":"Chimenti","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jhet.110","article-title":"Synthesis and biological evaluation of novel conjugated coumarin-thiazole systems","volume":"46","author":"Chimenti","year":"2009","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib46","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1021\/jm100120s","article-title":"Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines","volume":"53","author":"Chimenti","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/c0md00014k","article-title":"Synthesis and selective inhibition of human monoamine oxidases of a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones","volume":"1","author":"Chimenti","year":"2010","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2012.10.035_bib48","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1021\/jm1013709","article-title":"Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties","volume":"54","author":"Desideri","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib49","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.ejmech.2010.07.009","article-title":"Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase","volume":"45","author":"Maccioni","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib50","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1016\/j.bmcl.2010.07.013","article-title":"New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors","volume":"20","author":"Matos","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2012.10.035_bib51","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1016\/j.bmc.2010.06.007","article-title":"Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors","volume":"18","author":"Chimenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib52","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ejmech.2009.11.003","article-title":"Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives","volume":"45","author":"Chimenti","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib53","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bmc.2009.12.029","article-title":"A\u00a0new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors","volume":"18","author":"Chimenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib54","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.lfs.2010.04.001","article-title":"Antidepressant-like profile and MAO-A inhibitory activity of 4-propyl-2H-benzo[h]-chromen-2-one","volume":"86","author":"Vergel","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2012.10.035_bib55","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ejmech.2011.01.033","article-title":"Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives","volume":"46","author":"Delogu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib56","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1021\/jm060441e","article-title":"Impact of species-dependent differences on screening, design, and development of MAO B inhibitors","volume":"49","author":"Novaroli","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib57","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2006.03.190","article-title":"Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity","volume":"344","author":"Y\u00e1\u00f1ez","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2012.10.035_bib58","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/jm200716y","article-title":"Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors","volume":"54","author":"Matos","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib59","series-title":"STATISTICA (Data Analysis Software System), Version 8.0","author":"StatSoft","year":"2007"},{"key":"10.1016\/j.ejmech.2012.10.035_bib60","series-title":"Dragon for Windows (Software for Molecular Descriptors Calculation)","author":"Talete","year":"2006"},{"key":"10.1016\/j.ejmech.2012.10.035_bib61","series-title":"Molecular Operating Environment (MOE)","year":"2008"},{"key":"10.1016\/j.ejmech.2012.10.035_bib62","series-title":"MODESLAB 1.0 (Molecular DEScriptors LABoratory) for Windows","author":"Gutierrez","year":"2002"},{"key":"10.1016\/j.ejmech.2012.10.035_bib63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11030-009-9181-5","article-title":"Chemometric descriptors in modeling the carbonic anhydrase inhibition activity of sulfonamide and sulfamate derivatives","volume":"14","author":"Sharma","year":"2010","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2012.10.035_bib64","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/tx200099j","article-title":"A\u00a0comprehensive support vector machine binary HERG classification model based on extensive but biased end point HERG data sets","volume":"24","author":"Shen","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2012.10.035_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/138955708783744128","article-title":"How the parts organize in the whole? A top-down view of molecular descriptors and properties for QSAR and drug design","volume":"8","author":"Estrada","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1469-1809.1936.tb02137.x","article-title":"The use of multiple measurements in taxonomic problems","volume":"7","author":"Fisher","year":"1936","journal-title":"Ann. Eugen."},{"key":"10.1016\/j.ejmech.2012.10.035_bib67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.chemolab.2005.12.002","article-title":"Application of the replacement method as a novel variable selection strategy in QSAR. 1. Carcinogenic potential","volume":"81","author":"Helguera","year":"2006","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.ejmech.2012.10.035_bib68","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1021\/ci2003076","article-title":"Two new parameters based on distances in a receiver operating characteristic chart for the selection of classification models","volume":"51","author":"Perez-Garrido","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2012.10.035_bib69","series-title":"Nature-inspired Methods in Chemometrics: Genetic Algorithms and Artificial Neural Networks","author":"Leardi","year":"2003"},{"key":"10.1016\/j.ejmech.2012.10.035_bib70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/qsar.19940130306","article-title":"Variable selection in QSAR studies. I. An evolutionary algorithm","volume":"13","author":"Kubinyi","year":"1994","journal-title":"Quant. Struct. Activity Relatsh."},{"key":"10.1016\/j.ejmech.2012.10.035_bib71","series-title":"Analysis and Visualization of Classifier Performance: Comparison under Imprecise Class and Cost Distributions","author":"Provost","year":"1997"},{"key":"10.1016\/j.ejmech.2012.10.035_bib72","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/jm000375v","article-title":"Improved scoring of ligand\u2212protein interactions using OWFEG free energy grids","volume":"44","author":"Pearlman","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib73","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","article-title":"Comparison of the predicted and observed secondary structure of T4 phage lysozyme","volume":"405","author":"Matthews","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2012.10.035_bib74","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/ci0100144","article-title":"Protocols for bridging the peptide to nonpeptide gap in topological similarity searches","volume":"41","author":"Sheridan","year":"2001","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2012.10.035_bib75","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/ci600426e","article-title":"Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem","volume":"47","author":"Truchon","year":"2007","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2012.10.035_bib76","series-title":"Chemometrics Methods in Molecular Design","first-page":"309","article-title":"Statistical validation of QSAR results","author":"Wold","year":"1995"},{"key":"10.1016\/j.ejmech.2012.10.035_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/026119290503300209","article-title":"Current status of methods for defining the applicability domain of (quantitative) structure\u2013activity relationships. The report and recommendations of ECVAM workshop 52","volume":"33","author":"Netzeva","year":"2005","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejmech.2012.10.035_bib78","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/ci060132x","article-title":"A\u00a0novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models","volume":"46","author":"Zhang","year":"2006","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2012.10.035_bib79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11030-009-9115-2","article-title":"Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors","volume":"13","author":"Melagraki","year":"2009","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2012.10.035_bib80","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1289\/ehp.5758","article-title":"Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs","volume":"111","author":"Eriksson","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2012.10.035_bib81","series-title":"Combining Pattern Classifiers. Methods and Algorithms","author":"Kuncheva","year":"2004"},{"key":"10.1016\/j.ejmech.2012.10.035_bib82","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1021\/jm00209a006","article-title":"Benzopyrones. 14. Synthesis and antiallergic properties of some N-tetrazolylcarboxamides and related compounds","volume":"21","author":"Ellis","year":"1978","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib83","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/p29910000927","article-title":"Chromone studies. Part 3. NMR analysis of rotational isomerism in 4-oxo-4H-chromene-2-carboxamides","volume":"2","author":"Davidson","year":"1991","journal-title":"J.\u00a0Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.ejmech.2012.10.035_bib84","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.ejmech.2008.10.027","article-title":"New insights into the antioxidant activity of hydroxycinnamic acids: synthesis and physicochemical characterization of novel halogenated derivatives","volume":"44","author":"Gaspar","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib85","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1021\/jm021099i","article-title":"Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues","volume":"46","author":"Hadjeri","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib86","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/jm010382z","volume":"45","author":"Ishizuka","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib87","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1016\/j.tet.2005.05.081","article-title":"Chromone derivatives which bind to human hair","volume":"61","author":"Walenzyk","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2012.10.035_bib88","first-page":"117","article-title":"Recherche de compos\u00e9s antiallergiques d\u00e9riv\u00e9s de \u013ahydroxym\u00e9thyl-2 chromone et analogues structuraux","volume":"20","author":"Payard","year":"1985","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib89","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.bmc.2007.01.008","article-title":"Synthesis and insecticidal activity of chromanone and chromone analogues of diacylhydrazines","volume":"15","author":"Zhao","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.10.035_bib90","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1081\/SCC-120023445","article-title":"Improved selective reduction of 3-formylchromones using basic alumina and 2-propanol","volume":"33","author":"Araya-Maturana","year":"2003","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2012.10.035_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chemolab.2003.10.003","article-title":"A\u00a0distance measure between models: a tool for similarity\/diversity analysis of model populations","volume":"70","author":"Todeschini","year":"2004","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.ejmech.2012.10.035_bib92","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1021\/bi9002106","article-title":"Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B","volume":"48","author":"Upadhyay","year":"2009","journal-title":"Biochemistry"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412006393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412006393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T23:57:03Z","timestamp":1714521423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523412006393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":92,"alternative-id":["S0223523412006393"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2012.10.035","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}